205448-65-3

基本信息
7-甲氧基-4-氧代-1
4-二氫喹啉-6-羧酸甲酯
4-氧代-7-甲氧基-1,4-二氫喹啉-6-甲酸甲酯
1,4-二氫-7-甲氧基-4-氧代-6-喹啉羧酸甲酯
7-甲氧基-4-氧代-1,4-二氫喹啉-6-羧酸甲酯
FMX14227-A2
Lenvatinib Intermediate3
Methyl 7-Methoxy-4-oxo-1
4-dihydroquinoline-6-carboxylate
methyl 4-hydroxy-7-methoxyquinoline-6-carboxylate
7-Methoxy-4-oxo-1,4-dihydroquinoline-6-carboxylate
Methyl 7-Methoxy-4-oxo-1,4-dihydroquinoline-6-carboxylate
1,4-Dihydro-7-methoxy-4-oxo-6-quinolinecarboxylic acid methyl ester
7-Methoxy-4-oxo-1,4-dihydro-quinoline-6-carboxylic acid methyl ester
物理化學(xué)性質(zhì)
制備方法

205448-64-2

205448-65-3
以4-((2,2-二甲基-4,6-二氧代-1,3-二噁烷-5-基)甲基氨基)-2-甲氧基苯甲酸甲酯為原料合成7-甲氧基-4-氧代-1,4-二氫喹啉-6-羧酸甲酯的一般步驟:將5-((3-甲氧基-4-甲氧基羰基苯胺基)亞甲基-2,2-二甲基-1,3-二惡烷-4,6-二酮(10g,29.8mmol)懸浮于DOWTHERM A(125ml)中,并在30分鐘內(nèi)加熱至180-190℃。原料在100℃下溶解,二氧化碳在約180℃下開始釋放。繼續(xù)加熱30分鐘后停止加熱。隨著反應(yīng)混合物冷卻,產(chǎn)物逐漸析出。當(dāng)溫度降至40℃時,加入乙醚并將混合物攪拌30分鐘。通過過濾收集固體產(chǎn)物,用乙醚洗滌,并在真空下干燥,得到7-甲氧基-6-甲氧基羰基-1,4-二氫喹啉-4-酮(5.56g,收率80%)。產(chǎn)物的結(jié)構(gòu)通過1H NMR光譜確認(rèn):(DMSO-d6)δ 3.80(s,3H);3.85(s,3H);5.95(d,1H);7.00(s,1H);7.85(d,1H);8.40(s,1H);11.6(br s,1H);MS-ESI:234 [MH]+。
參考文獻:
[1] Patent: US6809097, 2004, B1. Location in patent: Page column 67
[2] Journal of Medicinal Chemistry, 2008, vol. 51, # 6, p. 1649 - 1667
[3] Journal of Medicinal Chemistry, 2008, vol. 51, # 6, p. 1668 - 1680
[4] Patent: EP1724268, 2006, A1. Location in patent: Page/Page column 48
[5] Patent: EP3293177, 2018, A1. Location in patent: Paragraph 0199; 0201